# BlackRock Mid-Cap Growth Equity R (BMRRX)

> Source: Nexqual · https://nexqual.com/BMRRX · data as of 2026-10-24 00:00 UTC · cite as "Nexqual, BlackRock Mid-Cap Growth Equity R (BMRRX), nexqual.com/BMRRX" · informational, not investment advice.

**Price:** USD 22.32 (-0.40% on the day) · last close of Oct 23, 2026; US market closed, not a live price. Prev close 22.41 · day 22.32–22.32 · 52w 22.32–36.43 · market cap null · NAS

## Key facts
- Total return with dividends: 1Y -10.3% vs S&P 500 +13.4%; 5Y -18.5% vs S&P 500 +76.9%.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-24) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | -10.3% | -18.5% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | -10.3% | -4.0% |
| Volatility (annualized) | 24.1% | 24.6% |
| Max drawdown | -17.0% (Jun 2026→Oct 2026) | -45.5% (Nov 2021→Oct 2022) |

## Peers
BMGCX (BlackRock Mid Cap Growth Equity) USD 13.92 -0.00% · BMGAX (BlackRock Mid Cap Growth Equity) USD 23.47 +0.00% · BGSRX (BlackRock Science & Technology ) USD 77.26 -0.00% · BHSRX (BlackRock Health Sciences Oppor) USD 63.09 -0.00% · CMGSX (BlackRock Funds Mid-Cap Growth ) USD 25.25 +0.00%

## More
Full page: https://nexqual.com/BMRRX · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt